SlideShare a Scribd company logo
PRESENTED BY :- MANASI MOHARANA
M.Sc. TUTOR , SNC
DEFINITION
 Yellow fever is a zoonotic disease caused by an
arbovirus
 It affects principally monkeys and other vertebrates
in tropical America and Africa and is transmitted to
man by certain culicine mosquitoes.
 It shares clinical features with other viral
haemorrhagic fevers (e.g., dengue HF, Lassa fever)
but is characterized by more severe hepatic and
renal involvement.
EPIDEMIOLOGICAL DETERMINANTS
 Agent factors
(a) AGENT : The causative agent, FlaviiJirus
fibricus formerly classified as a group B arbovirus, is
a member of the togavirus family..
(b) RESERVOIR OF INFECTION :
In forest areas, the reservoir of infection is mainly
monkeys and forest mosquitoes.
In urban areas, the reservoir is man (subclinical and
clinical cases) besides Aedes aegypti mosquitoes.
EPIDEMIOLOGICAL DETERMINANTS
(c) PERIOD OF COMMUNICABILITY :
(i) MAN : Blood of patients is infective during the
first 3 to 4 days of illness.
(ii) MOSQUITOES: After an "extrinsic incubation
period" of 8 to 12 days, the mosquito becomes
infective. The virus multiplies in the insect vector.
After becoming infective, the mosquito remains
so for life.
HOST FACTORS
 (a) AGE AND SEX : All ages and both sexes are
susceptible to yellow fever in the absence of
immunity.
 (b) OCCUPATION : Persons whose occupation
brings them in contact with forests (wood cutters,
hunters) where yellow fever is endemic are
exposed to the risk of infection.
 (c) IMMUNITY : One attack of yellow fever gives
lifelong immunity; second attacks are unknown.
Infants born of immune mothers have antibodies up
to 6 months of life.
ENVIROMENTAL FACTORS
 (a) CLIMATE : A temperature of 24 deg.C or over is
required for the multiplication of the virus in the
mosquito.
It should be accompanied by a relative humidity of
over 60 per cent for the mosquitoes to live long
enough to convey the disease.
 (b) SOCIAL FACTORS : In Africa, urbanization is
leading to the extension of yellow fever. In addition,
the expanding population is encroaching on areas
that were previously sparsely populated, thereby
bringing man closer to· the jungle cycles of yellow
fever..
MODES OF TRANSMISSION
 There are three known cycles of transmission, the jungle,
intermediate and the urban cycles .
1. Sylvatic (or jungle) yellow fever : In tropical rainforests,
yellow fever occurs in monkeys that are infected by wild
mosquitoes. The infected monkeys then pass the virus to
other mosquitoes that feed on them.
The infected mosquitoes bite humans entering the forest,
resulting in occasional cases of yellow fever. The majority of
infections·occur in young men working in the forest (e.g. for
logging)
CONT..
2. Intermediate yellow fever.
 In humid or semi-humid parts of Africa, small-scale
epidemics occur, Semi-domestic mosquitoes (that breed in
the wild and around households) infect both monkeys and
humans.
 Increased contact between people and infected
mosquitoes leads to transmission. This is the most
common type of outbreak in Africa.
CONT..
3. Urban yellow fever.
 Large epidemics occur when infected people
introduce the virus into densely populated areas
with a high number of non-immune people and
Aedes mosquitoes.
 Infected mosquitoes transmit the virus from person
to person
TREATMENT
 There is no specific treatment for yellow fever, only
supportive care to treat dehydration and fever.
 Associated bacterial infections can be treated with
antibiotics. Supportive care may improve outcomes for
seriously ill patients.
INCUBATION PERIOD:
 3 to 6 days (6 days recognized under International Health
Regulations).
CONTROL OF YELLOW FEVER
1. Jungle yellow fever :
 Jungle yellow fever
continues to be an
uncontrollable disease.
 The virus maintains itself
in the animal kingdom.
 Mosquito control is difficult
and can be considered only
in restricted areas.
 Vaccination of humans with
17D vaccine is the only
control measure
CONTROL OF YELLOW FEVER
2. Urban yellow fever :-
1.VACCINATION:Rapid immunization of the population at
risk is the most effective control strategy for yellow fever.
For international use, the approved vaccine is the 17D
vaccine.
 It is a live attenuated vaccine prepared from a non-
virulent strain (17D strain).
 It has to be stored between +5 and -30 deg.C, preferably
below zero deg.C until reconstituted with the sterile, cold
physiological saline diluent provided
CONTROL OF YELLOW FEVER
 Reconstituted vaccine should be kept on ice, away from
sunlight, and discarded if not used within half an hour.
 The vaccine is administered subcutaneously at the
insertion of deltoid in a single dose of 0.5 ml irrespective
of age.
 Immunity begins to appear on the 7th day and lasts for
more than 35 years, and possibly for life .
 However, WHO recommends revaccination after 10
years for international travel.
CONT...
 The risk of death from yellow fever is much higher than
the risks related to the vaccine. People who should not be
vaccinated include
(a) children aged under 9 months for routine
immunization (or under 6 months during an epidemic)
(b) pregnant women - except during a yellow fever
outbreak when the risk of infection is high.
(c) people with severe allergies to egg protein.
(d) people with severe immunodeficiency caused
by symptomatic HIV/AIDS or other causes, or in the
presence of thymus disorder.
CONTROL OF YELLOW FEVER
2. VECTOR CONTROL :- The other principal method of
preventing yellow fever is through intensive vector control.
 vigorous anti-adult and anti-larval measures.
 The long-term policy should be based on organized
"source reduction" methods (e.g., elimination of breeding
places) supported by health education aimed at securing
community participation.
 Personal protection against contact with insects is of major
importance in integrated vector control.
 Such protection may include the use of repellents,
mosquito nets, mosquito coils and fumigation mats
CONTROL OF YELLOW FEVER
3.SURVEILLANCE :-
 For the surveillance of Aedes mosquitoes, the WHO
uses an index known as Aedes aegypti index. This
is a house index and is defined as "the percentage
of houses and their premises, in a limited well-
defined area, showing actual breeding of Aedes
aegypti larvae".
 This index should not be more than 1 per cent in
towns and seaports in endemic areas to ensure
freedom from yellow fever.
INTERNATIONAL MEASURES
 The virus of yellow fever could get imported into
India in two ways:
1 :Through infected travellers (clinical and subclinical
cases), and
2 :Through infected mosquitoes. Measures designed
to restrict the spread of yellow fever are specified in
the "International Health Regulations" of WHO .
INTERNATIONAL MEASURES
Broadly these comprise :
(i) TRAVELLERS :
 All travellers (including infants) exposed to the risk of
yellow fever or passing through endemic zones of yellow
fever must possess a valid international certificate of
vaccination against yellow fever before they are allowed to
enter yellow fever "receptive" areas.
 If no such certificate is available, the traveller is placed on
quarantine, in a mosquito-proof ward, for 6 days from the
date of leaving an infected area.
 If the traveller arrives before the certificate becomes
"valid", he is isolated till the certificate becomes valid.
CONT..
(ii) MOSQUITOES :
 The aircraft and ships arriving from endemic areas are
subjected to aerosol spraying with prescribed insecticides
on arrival for destruction of insect vectors.
 Further, airports and seaports are kept free from the
breeding of insect vectors over an area extending at least
400 metres around their perimeters.
INTERNATIONAL CERTIFICATE OF VACCINATION
 India and most other countries require a valid certificate
of vaccination against yellow fever from travellers
coming from infected areas.
 The validity of the certificate begins 10 days after the
date of vaccination and extends up to 10 years.
 Revaccination performed before the end of the validity of
the certificate renders the certificate valid for a further
period of 10 years starting on the day of revaccination.
ANY DOUBT

More Related Content

What's hot

yellow fever.pptx
yellow fever.pptxyellow fever.pptx
yellow fever.pptx
microarunkumar
 
Dengue fever
Dengue feverDengue fever
Dengue fever
Medical Knowledge
 
Yellow fever virus
Yellow fever virusYellow fever virus
Yellow fever virus
Creative-Diagnostics
 
Small pox
Small poxSmall pox
Small pox
Abino David
 
Epidemiology and control measures for Yellow fever
Epidemiology and control measures for Yellow fever Epidemiology and control measures for Yellow fever
Epidemiology and control measures for Yellow fever
AB Rajar
 
Measles.pptx
Measles.pptxMeasles.pptx
Measles.pptx
ABHIJIT BHOYAR
 
Chikungunya
Chikungunya Chikungunya
Chikungunya
arun raj
 
Chikungunya fever
Chikungunya feverChikungunya fever
Chikungunya fever
Arifa T N
 
EPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIAEPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIA
MAHESWARI JAIKUMAR
 
Japanese encephalitis
Japanese encephalitis Japanese encephalitis
Japanese encephalitis
Nikkin T
 
Zika virus
Zika virusZika virus
Zika virus
Wal
 
Japanese encephalitis epidemiology
Japanese encephalitis epidemiologyJapanese encephalitis epidemiology
Japanese encephalitis epidemiology
utpal sharma
 
Dengue fever
Dengue feverDengue fever
Swine flu ppt
Swine flu pptSwine flu ppt
Swine flu ppt
Jignesh Pingul
 
Measles (rubeola)
Measles (rubeola)Measles (rubeola)
Measles (rubeola)
lelissard
 
Chikungunya virus
Chikungunya virus  Chikungunya virus
Chikungunya virus
Amjad Afridi
 

What's hot (20)

yellow fever.pptx
yellow fever.pptxyellow fever.pptx
yellow fever.pptx
 
Dengue fever
Dengue feverDengue fever
Dengue fever
 
Yellow fever virus
Yellow fever virusYellow fever virus
Yellow fever virus
 
Small pox
Small poxSmall pox
Small pox
 
Epidemiology and control measures for Yellow fever
Epidemiology and control measures for Yellow fever Epidemiology and control measures for Yellow fever
Epidemiology and control measures for Yellow fever
 
Plague
Plague Plague
Plague
 
Dengue
DengueDengue
Dengue
 
Measles.pptx
Measles.pptxMeasles.pptx
Measles.pptx
 
Chikungunya
Chikungunya Chikungunya
Chikungunya
 
Chikungunya fever
Chikungunya feverChikungunya fever
Chikungunya fever
 
EPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIAEPIDEMIOLOGY OF MALARIA
EPIDEMIOLOGY OF MALARIA
 
Japanese encephalitis
Japanese encephalitis Japanese encephalitis
Japanese encephalitis
 
Zika virus
Zika virusZika virus
Zika virus
 
Japanese encephalitis epidemiology
Japanese encephalitis epidemiologyJapanese encephalitis epidemiology
Japanese encephalitis epidemiology
 
Dengue fever
Dengue feverDengue fever
Dengue fever
 
Swine flu ppt
Swine flu pptSwine flu ppt
Swine flu ppt
 
Swine Flu & Aids
Swine Flu & AidsSwine Flu & Aids
Swine Flu & Aids
 
Measles (rubeola)
Measles (rubeola)Measles (rubeola)
Measles (rubeola)
 
Chikungunya virus
Chikungunya virus  Chikungunya virus
Chikungunya virus
 
Measles
MeaslesMeasles
Measles
 

Similar to Yellow fever

Yellow fever.pptx
Yellow fever.pptxYellow fever.pptx
Yellow fever.pptx
nitika245
 
Epidemiology of bacterial zoonotic diseases with their prevention and control
Epidemiology of bacterial zoonotic diseases with their prevention and controlEpidemiology of bacterial zoonotic diseases with their prevention and control
Epidemiology of bacterial zoonotic diseases with their prevention and control
Saudamini Sharma
 
Yellow fever mkk
Yellow fever  mkkYellow fever  mkk
Yellow fever mkk
MohamedKhamis77
 
Crimean congo hemorrhagic fever
Crimean congo hemorrhagic feverCrimean congo hemorrhagic fever
Crimean congo hemorrhagic feverismailzai
 
Arthropod-born infections
Arthropod-born infectionsArthropod-born infections
Arthropod-born infections
Dalia El-Shafei
 
PLAGUE.pptx
PLAGUE.pptxPLAGUE.pptx
PLAGUE.pptx
AlanSudhan
 
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptxEPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
YogeswaranElangovan2
 
Swine Flu Final
Swine Flu FinalSwine Flu Final
Swine Flu Final
pravinpawal
 
R A B I E S
R A B I E SR A B I E S
R A B I E S
Jack Frost
 
Congo virus by ishfaq ahmad
Congo virus by ishfaq ahmadCongo virus by ishfaq ahmad
Congo virus by ishfaq ahmad
ishfaqahmad afridi
 
Plague & leptospirosis class.pptx
Plague & leptospirosis class.pptxPlague & leptospirosis class.pptx
Plague & leptospirosis class.pptx
Shwetha Hariba
 
Bird flu
Bird fluBird flu
Bird flu
naheed butt
 
Covid 19 disease information ppt
Covid 19 disease information pptCovid 19 disease information ppt
Covid 19 disease information ppt
srinivas boddepalli
 
Neglected diseases---Overview
Neglected diseases---OverviewNeglected diseases---Overview
Neglected diseases---Overviewladdha1962
 
chapter 67 - Coronavirus disease - Copy.pptx
chapter 67 - Coronavirus disease - Copy.pptxchapter 67 - Coronavirus disease - Copy.pptx
chapter 67 - Coronavirus disease - Copy.pptx
GokulVV3
 
Arbovirus An Overview
Arbovirus An OverviewArbovirus An Overview
Arbovirus An Overview
drshweta04 sharma
 
Asignment 19.pdf
Asignment 19.pdfAsignment 19.pdf
Asignment 19.pdf
د حاتم البيطار
 
Ebola ppt
Ebola pptEbola ppt
Ebola ppt
Parthasarathi R
 

Similar to Yellow fever (20)

Yellow fever.pptx
Yellow fever.pptxYellow fever.pptx
Yellow fever.pptx
 
Epidemiology of bacterial zoonotic diseases with their prevention and control
Epidemiology of bacterial zoonotic diseases with their prevention and controlEpidemiology of bacterial zoonotic diseases with their prevention and control
Epidemiology of bacterial zoonotic diseases with their prevention and control
 
Yellow fever mkk
Yellow fever  mkkYellow fever  mkk
Yellow fever mkk
 
Crimean congo hemorrhagic fever
Crimean congo hemorrhagic feverCrimean congo hemorrhagic fever
Crimean congo hemorrhagic fever
 
Arthropod-born infections
Arthropod-born infectionsArthropod-born infections
Arthropod-born infections
 
PLAGUE.pptx
PLAGUE.pptxPLAGUE.pptx
PLAGUE.pptx
 
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptxEPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
EPIDEMIOLOGY OF YELLOW FEVER AND ITS PREVENTION AND.pptx
 
Swine Flu Final
Swine Flu FinalSwine Flu Final
Swine Flu Final
 
R A B I E S
R A B I E SR A B I E S
R A B I E S
 
Swine Flu Final
Swine Flu FinalSwine Flu Final
Swine Flu Final
 
Influenza
InfluenzaInfluenza
Influenza
 
Congo virus by ishfaq ahmad
Congo virus by ishfaq ahmadCongo virus by ishfaq ahmad
Congo virus by ishfaq ahmad
 
Plague & leptospirosis class.pptx
Plague & leptospirosis class.pptxPlague & leptospirosis class.pptx
Plague & leptospirosis class.pptx
 
Bird flu
Bird fluBird flu
Bird flu
 
Covid 19 disease information ppt
Covid 19 disease information pptCovid 19 disease information ppt
Covid 19 disease information ppt
 
Neglected diseases---Overview
Neglected diseases---OverviewNeglected diseases---Overview
Neglected diseases---Overview
 
chapter 67 - Coronavirus disease - Copy.pptx
chapter 67 - Coronavirus disease - Copy.pptxchapter 67 - Coronavirus disease - Copy.pptx
chapter 67 - Coronavirus disease - Copy.pptx
 
Arbovirus An Overview
Arbovirus An OverviewArbovirus An Overview
Arbovirus An Overview
 
Asignment 19.pdf
Asignment 19.pdfAsignment 19.pdf
Asignment 19.pdf
 
Ebola ppt
Ebola pptEbola ppt
Ebola ppt
 

Recently uploaded

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Saeid Safari
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
kevinkariuki227
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
addon Scans
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
i3 Health
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
pal078100
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Oleg Kshivets
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
touseefaziz1
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
SumeraAhmad5
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
NephroTube - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
KafrELShiekh University
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
Sujoy Dasgupta
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
vimalpl1234
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
Sapna Thakur
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Savita Shen $i11
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 

Recently uploaded (20)

Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists  Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
Flu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore KarnatakaFlu Vaccine Alert in Bangalore Karnataka
Flu Vaccine Alert in Bangalore Karnataka
 
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Ocular injury ppt Upendra pal optometrist upums saifai etawah
Ocular injury  ppt  Upendra pal  optometrist upums saifai etawahOcular injury  ppt  Upendra pal  optometrist upums saifai etawah
Ocular injury ppt Upendra pal optometrist upums saifai etawah
 
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
POST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its managementPOST OPERATIVE OLIGURIA and its management
POST OPERATIVE OLIGURIA and its management
 
heat stroke and heat exhaustion in children
heat stroke and heat exhaustion in childrenheat stroke and heat exhaustion in children
heat stroke and heat exhaustion in children
 
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.GawadHemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
 
Ophthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE examOphthalmology Clinical Tests for OSCE exam
Ophthalmology Clinical Tests for OSCE exam
 
Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...Couples presenting to the infertility clinic- Do they really have infertility...
Couples presenting to the infertility clinic- Do they really have infertility...
 
Knee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdfKnee anatomy and clinical tests 2024.pdf
Knee anatomy and clinical tests 2024.pdf
 
NVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control programNVBDCP.pptx Nation vector borne disease control program
NVBDCP.pptx Nation vector borne disease control program
 
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model SafeSurat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
Surat @ℂall @Girls ꧁❤8527049040❤꧂@ℂall @Girls Service Vip Top Model Safe
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 

Yellow fever

  • 1. PRESENTED BY :- MANASI MOHARANA M.Sc. TUTOR , SNC
  • 2. DEFINITION  Yellow fever is a zoonotic disease caused by an arbovirus  It affects principally monkeys and other vertebrates in tropical America and Africa and is transmitted to man by certain culicine mosquitoes.  It shares clinical features with other viral haemorrhagic fevers (e.g., dengue HF, Lassa fever) but is characterized by more severe hepatic and renal involvement.
  • 3. EPIDEMIOLOGICAL DETERMINANTS  Agent factors (a) AGENT : The causative agent, FlaviiJirus fibricus formerly classified as a group B arbovirus, is a member of the togavirus family.. (b) RESERVOIR OF INFECTION : In forest areas, the reservoir of infection is mainly monkeys and forest mosquitoes. In urban areas, the reservoir is man (subclinical and clinical cases) besides Aedes aegypti mosquitoes.
  • 4. EPIDEMIOLOGICAL DETERMINANTS (c) PERIOD OF COMMUNICABILITY : (i) MAN : Blood of patients is infective during the first 3 to 4 days of illness. (ii) MOSQUITOES: After an "extrinsic incubation period" of 8 to 12 days, the mosquito becomes infective. The virus multiplies in the insect vector. After becoming infective, the mosquito remains so for life.
  • 5. HOST FACTORS  (a) AGE AND SEX : All ages and both sexes are susceptible to yellow fever in the absence of immunity.  (b) OCCUPATION : Persons whose occupation brings them in contact with forests (wood cutters, hunters) where yellow fever is endemic are exposed to the risk of infection.  (c) IMMUNITY : One attack of yellow fever gives lifelong immunity; second attacks are unknown. Infants born of immune mothers have antibodies up to 6 months of life.
  • 6. ENVIROMENTAL FACTORS  (a) CLIMATE : A temperature of 24 deg.C or over is required for the multiplication of the virus in the mosquito. It should be accompanied by a relative humidity of over 60 per cent for the mosquitoes to live long enough to convey the disease.  (b) SOCIAL FACTORS : In Africa, urbanization is leading to the extension of yellow fever. In addition, the expanding population is encroaching on areas that were previously sparsely populated, thereby bringing man closer to· the jungle cycles of yellow fever..
  • 7. MODES OF TRANSMISSION  There are three known cycles of transmission, the jungle, intermediate and the urban cycles . 1. Sylvatic (or jungle) yellow fever : In tropical rainforests, yellow fever occurs in monkeys that are infected by wild mosquitoes. The infected monkeys then pass the virus to other mosquitoes that feed on them. The infected mosquitoes bite humans entering the forest, resulting in occasional cases of yellow fever. The majority of infections·occur in young men working in the forest (e.g. for logging)
  • 8. CONT.. 2. Intermediate yellow fever.  In humid or semi-humid parts of Africa, small-scale epidemics occur, Semi-domestic mosquitoes (that breed in the wild and around households) infect both monkeys and humans.  Increased contact between people and infected mosquitoes leads to transmission. This is the most common type of outbreak in Africa.
  • 9. CONT.. 3. Urban yellow fever.  Large epidemics occur when infected people introduce the virus into densely populated areas with a high number of non-immune people and Aedes mosquitoes.  Infected mosquitoes transmit the virus from person to person
  • 10. TREATMENT  There is no specific treatment for yellow fever, only supportive care to treat dehydration and fever.  Associated bacterial infections can be treated with antibiotics. Supportive care may improve outcomes for seriously ill patients. INCUBATION PERIOD:  3 to 6 days (6 days recognized under International Health Regulations).
  • 11. CONTROL OF YELLOW FEVER 1. Jungle yellow fever :  Jungle yellow fever continues to be an uncontrollable disease.  The virus maintains itself in the animal kingdom.  Mosquito control is difficult and can be considered only in restricted areas.  Vaccination of humans with 17D vaccine is the only control measure
  • 12. CONTROL OF YELLOW FEVER 2. Urban yellow fever :- 1.VACCINATION:Rapid immunization of the population at risk is the most effective control strategy for yellow fever. For international use, the approved vaccine is the 17D vaccine.  It is a live attenuated vaccine prepared from a non- virulent strain (17D strain).  It has to be stored between +5 and -30 deg.C, preferably below zero deg.C until reconstituted with the sterile, cold physiological saline diluent provided
  • 13. CONTROL OF YELLOW FEVER  Reconstituted vaccine should be kept on ice, away from sunlight, and discarded if not used within half an hour.  The vaccine is administered subcutaneously at the insertion of deltoid in a single dose of 0.5 ml irrespective of age.  Immunity begins to appear on the 7th day and lasts for more than 35 years, and possibly for life .  However, WHO recommends revaccination after 10 years for international travel.
  • 14. CONT...  The risk of death from yellow fever is much higher than the risks related to the vaccine. People who should not be vaccinated include (a) children aged under 9 months for routine immunization (or under 6 months during an epidemic) (b) pregnant women - except during a yellow fever outbreak when the risk of infection is high. (c) people with severe allergies to egg protein. (d) people with severe immunodeficiency caused by symptomatic HIV/AIDS or other causes, or in the presence of thymus disorder.
  • 15. CONTROL OF YELLOW FEVER 2. VECTOR CONTROL :- The other principal method of preventing yellow fever is through intensive vector control.  vigorous anti-adult and anti-larval measures.  The long-term policy should be based on organized "source reduction" methods (e.g., elimination of breeding places) supported by health education aimed at securing community participation.  Personal protection against contact with insects is of major importance in integrated vector control.  Such protection may include the use of repellents, mosquito nets, mosquito coils and fumigation mats
  • 16. CONTROL OF YELLOW FEVER 3.SURVEILLANCE :-  For the surveillance of Aedes mosquitoes, the WHO uses an index known as Aedes aegypti index. This is a house index and is defined as "the percentage of houses and their premises, in a limited well- defined area, showing actual breeding of Aedes aegypti larvae".  This index should not be more than 1 per cent in towns and seaports in endemic areas to ensure freedom from yellow fever.
  • 17. INTERNATIONAL MEASURES  The virus of yellow fever could get imported into India in two ways: 1 :Through infected travellers (clinical and subclinical cases), and 2 :Through infected mosquitoes. Measures designed to restrict the spread of yellow fever are specified in the "International Health Regulations" of WHO .
  • 18. INTERNATIONAL MEASURES Broadly these comprise : (i) TRAVELLERS :  All travellers (including infants) exposed to the risk of yellow fever or passing through endemic zones of yellow fever must possess a valid international certificate of vaccination against yellow fever before they are allowed to enter yellow fever "receptive" areas.  If no such certificate is available, the traveller is placed on quarantine, in a mosquito-proof ward, for 6 days from the date of leaving an infected area.  If the traveller arrives before the certificate becomes "valid", he is isolated till the certificate becomes valid.
  • 19. CONT.. (ii) MOSQUITOES :  The aircraft and ships arriving from endemic areas are subjected to aerosol spraying with prescribed insecticides on arrival for destruction of insect vectors.  Further, airports and seaports are kept free from the breeding of insect vectors over an area extending at least 400 metres around their perimeters.
  • 20. INTERNATIONAL CERTIFICATE OF VACCINATION  India and most other countries require a valid certificate of vaccination against yellow fever from travellers coming from infected areas.  The validity of the certificate begins 10 days after the date of vaccination and extends up to 10 years.  Revaccination performed before the end of the validity of the certificate renders the certificate valid for a further period of 10 years starting on the day of revaccination.